Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interplay between human papillomaviruses and dendritic cells.

R Offringa1, A de Jong, R E M Toes

  • 1Tumor Immunology Group, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Current Topics in Microbiology and Immunology
|June 12, 2003
PubMed
Summary

Human papillomavirus (HPV) infection relies on keratinocyte differentiation, with Langerhans cells (LCs) crucial for antiviral immunity. Effective immune strategies must consider LC-driven antigen presentation for preventing and treating HPV-induced diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.

Rheumatology (Oxford, England)·2026
Same author

Pyocyanin produced by <i>Pseudomonas aeruginosa</i> creates legacy effects that promote antibiotic resistance evolution in enterococci.

Antimicrobial agents and chemotherapy·2026
Same author

Selective Elimination of Autoreactive B Cells Using Multivalent Polyisocyanopeptide-Based Antigen-Toxin Conjugates.

Biomacromolecules·2026
Same author

Local immunosuppressive microenvironment underlies reduced responsiveness to imiquimod treatment in recurrent or residual cervical HSIL.

Gynecologic oncology reports·2026
Same author

Site-specific profiling of structure and function of Igµ B cell receptor glycans.

Nature communications·2026
Same author

Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025

Area of Science:

  • Immunology
  • Virology
  • Dermatology

Background:

  • Human papillomavirus (HPV) infects keratinocytes, utilizing their differentiation program.
  • Antigen-presenting cells, specifically Langerhans cells (LCs), are central to initiating antiviral immunity against HPV.
  • HPV infection is confined to epithelia, limiting direct access of infected cells to lymphoid organs.

Purpose of the Study:

  • To elucidate the role of Langerhans cells (LCs) in priming T cell-dependent immunity against HPV.
  • To understand how HPV evades immune detection and leads to persistent infections and cancer.
  • To explore immune intervention strategies for preventing and treating HPV-induced diseases.

Main Methods:

  • The study focuses on the mechanism of antigen presentation by LCs, particularly cross-presentation of viral antigens.

Related Experiment Videos

  • It examines the induction of systemic and intraepithelial immune responses against HPV.
  • Analysis of epidemiological data to understand immune system evasion by HPV.

    • Main Results:

    • Priming of antiviral T cells relies exclusively on cross-presentation of HPV antigens by LCs.
    • Effective anti-HPV immunity involves systemic responses and intraepithelial immune surveillance.
    • High rates of spontaneous clearance of HPV infections and lesions indicate functional LC-driven immunity.

    Conclusions:

    • The LC-driven antigen presentation machinery is generally effective against HPV.
    • Compromised immune surveillance allows HPV to cause persistent infections and cancer.
    • Immune intervention strategies targeting HPV should consider the induction and effector phases of intraepithelial immunity.